Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19 A Julià, I Bonafonte-Pardàs, A Gómez, M López-Lasanta, ... Scientific reports 11 (1), 1-14, 2021 | 15 | 2021 |
Blocking of the CD80/86 axis as a therapeutic approach to prevent progression to more severe forms of COVID-19 A Julià, I Bonafonte, A Gómez, M López-Lasanta, M López-Corbeto, ... arXiv preprint arXiv:2005.10055, 2020 | 1 | 2020 |
B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4 AM Afzali, L Nirschl, C Sie, M Pfaller, O Ulianov, T Hassler, C Federle, ... Nature, 1-9, 2024 | | 2024 |
Large-scale characterization of cell niches in spatial atlases using bio-inspired graph learning S Birk, I Bonafonte-Pardàs, AM Feriz, A Boxall, E Agirre, F Memi, ... bioRxiv, 2024.02. 21.581428, 2024 | | 2024 |
Analyzing the contribution of different passively collected data to predict Stress and Depression I Bonafonte, C Bustos, A Larrazolo, GLM Luna, AG Arenas, X Baro, ... arXiv preprint arXiv:2310.13607, 2023 | | 2023 |
Identification of Immunological Processes Associated with the Response to Abatacept in Rheumatoid Arthritis Using Longitudinal Blood RNA-seq Analysis A Julia, ML Lasanta, A Gomez, I Bonafonte, R Sanmarti, C Marras, ... ARTHRITIS & RHEUMATOLOGY 71, 2019 | | 2019 |